|
|
By John Giantsidis, president, CyberActa, Inc.
September 2022 will be remembered as a seminal turning point for digital health in the U.S. With the FDA’s final guidance on clinical decision support (CDS) software, the FDA disregards a Congressional directive when it enacted the 21st Century Cures Act in 2016.
|